Kalaris Therapeutics Inc
General ticker "KLRS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $79.8M (TTM average)
Kalaris Therapeutics Inc does not follow the US Stock Market performance with the rate: -3.8%.
Estimated limits based on current volatility of 7.2%: low 6.84$, high 7.90$
Short-term KLRS quotes
Long-term KLRS plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $55.26MM |
| Operating Income | $-55.26MM |
| Non-Operating Income | $-3.51MM |
| R&D Expense | $12.34MM |
| Income(Loss) | $-58.77MM |
| Profit(Loss)* | $-58.77MM |
| Stockholders Equity | $113.31MM |
| Assets | $118.55MM |
| Operating Cash Flow | $-67.70MM |
| Investing Cash Flow | $95.00MM |
| Financing Cash Flow | $0.02MM |
| Earnings Per Share** | $-11.73 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.